Parexel appoints Jim Anthony as CCO and President, Parexel Biotech
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
NewCo’s pipeline includes five investigational medicines
Revenue increased 11.4 per cent to Rs. 8,545 crore
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Dilip Shanghvi to continue as the Executive Chairman of the Board
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Subscribe To Our Newsletter & Stay Updated